Cancer Vaccines
Reports from University of Birmingham advance knowledge in cancer vaccines
Published in Gene Therapy Weekly, February 19th, 2009
"This is a phase II clinical trial investigating the safety and efficacy of intravenous vaccination with mature autologous dendritic cells (DCs) pulsed ex vivo with a liver tumor cell line lysate (HepG2) in patients with advanced hepatocellular carcinoma (HCC). HCC is an attractive target for immunotherapy as evidenced by an active recruitment of tumor-infiltrating lymphocytes that are capable of lysing autologous tumor cells in ex vivo studies," scientists in Birmingham, the United Kingdom report.
"DCs are the most potent antigen-presenting cells, with the capacity to take up, process, and present tumor antigens to T cells and stimulate an immune response, thus...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-02-19)
More Articles from Gene Therapy Weekly
- Acute Gastroenteritis
Studies in the area of acute gastroenteritis reported from Mahidol University - Acute Lymphoblastic Leukemia
Scientists at University of Newcastle discuss research in acute lymphoblastic leukemia - Adenovirus
Scientists at Medical College release new data on adenovirus - Apoptosis
Researchers from University of Michigan publish new studies and findings in the area of apoptosis - Arrhythmia
Research in the area of arrhythmia reported from Columbia University - B-Cell Lymphoma
Research from G.H. Wang and colleagues has provided new data on B-cell lymphoma - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
